Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002356230 | SCV002654788 | uncertain significance | Inborn genetic diseases | 2022-06-11 | criteria provided, single submitter | clinical testing | The p.G2163S variant (also known as c.6487G>A), located in coding exon 24 of the WNK1 gene, results from a G to A substitution at nucleotide position 6487. The glycine at codon 2163 is replaced by serine, an amino acid with similar properties. This amino acid position is well conserved in available vertebrate species; however, serine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Revvity Omics, |
RCV003491096 | SCV004237548 | uncertain significance | not provided | 2023-06-29 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005215847 | SCV005852106 | uncertain significance | Neuropathy, hereditary sensory and autonomic, type 2A; Pseudohypoaldosteronism type 2C | 2024-10-28 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 2163 of the WNK1 protein (p.Gly2163Ser). This variant is present in population databases (rs766411372, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with WNK1-related conditions. ClinVar contains an entry for this variant (Variation ID: 1753793). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt WNK1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |